WHO settles India, EU medicine dispute
- What: The WHO has dropped the term ‘counterfeit’ and retained ‘falsified’ to describe medicines of inferior quality
- Why: The terms were being used interchangeably to confiscate Indian made generic drugs exported to other countries
- Indian made drugs were being shown as violating intellectual property
- Nearly 20 shipments of generic drugs, including basic antibiotics and anti-retrovirals, were detained between 2008 and 2009
- This is also a significant victory for the global access to medicines campaign
WHO seeks special U.N. session on TB II
- India shoulders the highest burden of 2.2 million cases a year
- PM Narendra Modi held a high-level meeting on TB on yesterday
- The UNGA meeting on TB is a strategy copied from the HIV movement
- The member states had adopted a political declaration to fast-track progress in combating the HIV/AIDS epidemic
WHO seeks special U.N. session on TB I
- What: The WHO is calling for the first United Nations General Assembly on the deadly but curable infection
- Why: Frustrated with a lack of political will shown by nations with a high burden of tuberculosis
- Context: The development follows the release of the Global TB report
- In it the WHO had to significantly revise the global burden of TB after a 34 per cent increase in cases reported from India
India to lead global coalition to fight epidemics
- India is all set to lead the global fight against epidemics as it is a key member of the newly formed Coalition for Epidemic Preparedness Innovations (CEPI)
- Headquarters at the Norwegian Institute for Public Health, in Oslo
- The coalition will not focus on diseases that already have sufficient attention, but will be guided by WHO’s R&D blueprint (2016)
- It lists eleven illnesses to focus on, including Chikungunya, Middle East Respiratory Syndrome (MERS), Crimean-Congo Haemorrhagic fever
- Dr K Vijay Raghavan, secretary, Department of Biotechnology, India, has been chosen as the chairperson of the interim board
WHO report on doctors in India
- News: A World Health Organisation study titled ‘The Health Workforce in India’ has sounded alarm on the doctors in India, based on data from Census 2001
- Key findings: Almost one-third of those who claimed to be allopathic doctors in 2001 were educated only up to the secondary school level and 57% did not have any medical qualification
- The situation was far worse in rural India, where just 18.8% of allopathic doctors had a medical qualification
- Female healthcare workers were found to be more educated and medically qualified than their male counterparts
- India has 36 medically qualified doctors per lakh population and 6 medically qualified nurses and midwives per lakh population
- Solution: There should be more attempts from the government to curb quackery (promotion of fraudulent or ignorant medical practices)
WHO to go in for long-awaited reform
- Member states of the WHO have agreed a long-awaited reform establishing a new Health Emergencies Programme
- Aim: To responds more quickly and effectively to emergency situations such as disease outbreaks & health emergencies
- Background: WH was accused of having wasted months before declaring war on the Ebola virus in west Africa
- Funds: An increase of $160 million in the existing programme budget for emergencies for 2016-2017 was approved
- In total, the new programme will have $494 million for the 2016-2017 fiscal year
WHO certifies vaccine maker GreenSignal Bio
GreenSignal is the second Indian company to get PQP certification from WHO
- The WHO has accorded PQP (Pre-qualification of Medicines Programme) certification to the GreenSignal Bio Pharma Pvt. Ltd., a BCG vaccine-making firm
- The certification helps the company to participate in the global immunisation programme
- This is facilitated through international procurement agencies such as UNICEF
- These global institutions go by the WHO’s list of pre-qualified products
- While making a decision on procurement for medicines for distribution in resource-limited nations
Let’s know about Mammography?
- A mammogram is an x-ray picture of human breast which can be used to check for breast cancer in women who have no signs or symptoms of the disease
- Mammography is the type of mammogram
- WHO recommends mammography for women aged over 50
- There is scientific evidence that it is effective in reducing breast cancer mortality in women in the 50–69 age group
- It has gained popularity globally over the years with the rising incidence of breast cancer
Let’s know about IARC?
- The International Agency for Research on Cancer is the specialised cancer agency of the WHO
- Its objective is to promote international collaboration in cancer research
- It publishes handbooks for various cancer types and it is referred to by clinicians across the globe
No mammography needed for women under 50: WHO
- According to International Agency for Research on Cancer (IARC), mammography has limited efficacy in the younger age band
- There is a risk of false positive results, over-diagnosis, and possibly radiation-induced cancer
- The screening for breast cancer aims to reduce mortality and morbidity associated with the advanced stages of the disease
- Women in the lower age groups should continue to do breast self-examination and undergo a clinical breast examination once a year
WHO declares end to Ebola epidemic
Studies continue to uncover new information about how long Ebola can last in bodily fluids.
- The World Health Organisation declared an end to the deadliest Ebola outbreak ever after no new cases emerged in Liberia.
- Though health officials warn that it will be several more months before the world is considered free of the disease that claimed more than 11,300 lives over 2 years.
- Some 17,000 survivors are trying to resume their lives though many battle mysterious, lingering side effects.
- Liberia, which along with Sierra Leone and Guinea was an epicentre of the latest outbreak, was first declared free of the disease last May.
- There is still ongoing risk of re-emergence of the disease because of persistence of the virus in a proportion of survivors.
:( We are working on most probable questions. Do check back this section.